
Eledon Pharmaceuticals, Inc.
ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31
Reports and events: 214 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-04-3013:03 ET | DEF 14A | Proxy statementPeriod 2018-06-13 | 0001564590-18-009747 |
| 2018-04-1716:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-18-119824 |
| 2018-04-0221:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-18-007316 |
| 2018-04-0221:46 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001564590-18-007314 |
| 2018-03-1915:16 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000249 |
| 2018-03-1217:38 ET | 8-K | 8.01 Other events | 0001564590-18-005165 |
| 2018-01-0817:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-18-000016 |
| 2017-11-2917:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-17-024356 |
| 2017-11-0816:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-17-022812 |
| 2017-11-0816:41 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001564590-17-022799 |
| 2017-11-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-17-021826 |
| 2017-09-2916:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-17-299533 |
| 2017-08-2217:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-17-264684 |
| 2017-08-1806:07 ET | DEF 14A | Proxy statementPeriod 2017-09-28 | 0001193125-17-261566 |
| 2017-08-1006:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-253437 |
| 2017-08-0916:30 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001193125-17-252847 |
| 2017-07-2514:55 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-17-234866 |
| 2017-07-1017:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-17-225327 |
| 2017-05-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-17-189230 |
| 2017-05-1912:15 ET | SC 13D | Ownership report, active investor | 0000947871-17-000387 |
| 2017-05-1616:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-17-172186 |
| 2017-05-1516:23 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-17-170677 |
| 2017-05-0316:06 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001193125-17-156191 |
| 2017-04-2816:20 ET | 8-K | 8.01 Other events | 0001193125-17-148228 |
| 2017-04-2517:04 ET | 10-K/A | Annual report, amendedPeriod 2016-12-31 | 0001193125-17-136933 |
| 2017-03-0917:00 ET | 8-K | 3.01 Delisting notice | 0001193125-17-077021 |
| 2017-03-0316:07 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001193125-17-069741 |
| 2017-02-0316:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-17-030723 |
| 2017-01-0515:11 ET | SC 13D | Ownership report, active investor | 0001193125-17-002838 |
| 2016-12-2209:41 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-801307 |
| 2016-11-0306:21 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001193125-16-757930 |
| 2016-10-1216:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-16-736743 |
| 2016-08-2216:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-16-687554 |
| 2016-08-0417:29 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001193125-16-672054 |
| 2016-08-0307:53 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-16-669173 |
| 2016-07-2616:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-16-658097 |
| 2016-06-1607:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-16-623006 |
| 2016-05-3107:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-16-607178 |
| 2016-05-1007:08 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001193125-16-584673 |
| 2016-04-2907:31 ET | DEF 14A | Proxy statementPeriod 2016-06-15 | 0001193125-16-566075 |
| 2016-03-1007:16 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001193125-16-499163 |
| 2016-01-0707:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-422911 |
| 2015-11-1007:44 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001193125-15-372762 |
| 2015-08-1216:04 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001193125-15-288074 |
| 2015-06-1807:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-15-226543 |
| 2015-06-1216:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-15-221806 |
| 2015-05-1206:19 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001193125-15-182900 |
| 2015-04-3017:00 ET | DEF 14A | Proxy statementPeriod 2015-06-17 | 0001193125-15-162493 |
| 2015-04-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-15-131300 |
| 2015-03-2616:36 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001193125-15-107051 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.